 | • レポートコード：MRC-IM30565 • 出版社/出版日：IMARC / 2023年2月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2022年に28億ドルであった世界のアレルギー免疫療法市場規模が2028年に50億ドルに達し、2023年から2028年の間に年平均9.8％成長すると予測しています。本調査レポートでは、アレルギー免疫療法の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、治療種類別（皮下免疫療法（SCIT）、舌下免疫療法（SLIT））分析、アレルギー種類別（アレルギー性鼻炎、喘息、食物アレルギー、毒物アレルギー、その他）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（欧州、北米、アジア、中東・アフリカ、中南米）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競合状況などの項目を掲載しています。また、本調査レポートに掲載されている企業情報には、ALK-Abello A/S、Allergy Therapeutics、Stallergenes Greer、HAL Allergy Holding B.V.、DBV Technologies、Merck KGaA、Aimmune Therapeutics、Circassia Pharmaceuticals、Anergis SA、Biomay AGなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のアレルギー免疫療法市場規模：治療種類別 - 皮下免疫療法（SCIT）の市場規模 - 舌下免疫療法（SLIT）の市場規模 ・世界のアレルギー免疫療法市場規模：アレルギー種類別 - アレルギー性鼻炎における市場規模 - 喘息における市場規模 - 食物アレルギーにおける市場規模 - 毒物アレルギーにおける市場規模 - その他アレルギーにおける市場規模 ・世界のアレルギー免疫療法市場規模：流通チャネル別 - 病院薬局チャネルの市場規模 - 小売薬局チャネルの市場規模 - オンライン薬局チャネルの市場規模 ・世界のアレルギー免疫療法市場規模：地域別 - 欧州のアレルギー免疫療法市場規模 - 北米のアレルギー免疫療法市場規模 - アジアのアレルギー免疫療法市場規模 - 中東・アフリカのアレルギー免疫療法市場規模 - 中南米のアレルギー免疫療法市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競合状況 |
The global allergy immunotherapies market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028.
Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system’s response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient’s life.
In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy immunotherapies market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on treatment type, allergy type and distribution channel.
Breakup by Treatment Type:
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
Breakup by Allergy Type:
Allergic Rhinitis
Asthma
Food Allergy
Venom Allergy
Others
Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Breakup by Region:
Europe
North America
Asia Pacific
Middle East and Africa
Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc.
Key Questions Answered in This Report
1. What was the size of the global allergy immunotherapies market in 2022?
2. What is the expected growth rate of the global allergy immunotherapies market during 2023-2028?
3. What are the key factors driving the global allergy immunotherapies market?
4. What has been the impact of COVID-19 on the global allergy immunotherapies market?
5. What is the breakup of the global allergy immunotherapies market based on the treatment type?
6. What is the breakup of the global allergy immunotherapies market based on the allergy type?
7. What is the breakup of the global allergy immunotherapies market based on the distribution channel?
8. What are the key regions in the global allergy immunotherapies market?
9. Who are the key players/companies in the global allergy immunotherapies market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Allergy Immunotherapies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Treatment Type
5.5 Market Breakup by Allergy Type
5.6 Market Breakup by Distribution Channel
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Treatment Type
6.1 Subcutaneous Immunotherapy (SCIT)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Sublingual Immunotherapy (SLIT)
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Allergy Type
7.1 Allergic Rhinitis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Asthma
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Food Allergy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Venom Allergy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 Europe
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 North America
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Asia Pacific
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 ALK-Abello A/S
14.3.2 Allergy Therapeutics
14.3.3 Stallergenes Greer
14.3.4 HAL Allergy Holding B.V.
14.3.5 DBV Technologies
14.3.6 Merck KGaA
14.3.7 Aimmune Therapeutics
14.3.8 Circassia Pharmaceuticals
14.3.9 Anergis SA
14.3.10 Biomay AG
Figure 2: Global: Allergy Immunotherapies Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Allergy Immunotherapies Market: Breakup by Treatment Type (in %), 2022
Figure 4: Global: Allergy Immunotherapies Market: Breakup by Allergy Type (in %), 2022
Figure 5: Global: Allergy Immunotherapies Market: Breakup by Distribution Channel (in %), 2022
Figure 6: Global: Allergy Immunotherapies Market: Breakup by Region (in %), 2022
Figure 7: Global: Allergy Immunotherapies Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Allergy Immunotherapies Industry: SWOT Analysis
Figure 9: Global: Allergy Immunotherapies Industry: Value Chain Analysis
Figure 10: Global: Allergy Immunotherapies Industry: Porter’s Five Forces Analysis
Figure 11: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Allergy Immunotherapies (Allergic Rhinitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Allergy Immunotherapies (Allergic Rhinitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Allergy Immunotherapies (Asthma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Allergy Immunotherapies (Asthma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Allergy Immunotherapies (Food Allergy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Allergy Immunotherapies (Food Allergy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Allergy Immunotherapies (Venom Allergy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Allergy Immunotherapies (Venom Allergy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Allergy Immunotherapies (Other Allergy Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Allergy Immunotherapies (Other Allergy Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Allergy Immunotherapies Market: Sales through Hospital Pharmacy (in Million US$), 2017 & 2022
Figure 26: Global: Allergy Immunotherapies Market Forecast: Sales through Hospital Pharmacy (in Million US$), 2023-2028
Figure 27: Global: Allergy Immunotherapies Market: Sales through Retail Pharmacy (in Million US$), 2017 & 2022
Figure 28: Global: Allergy Immunotherapies Market Forecast: Sales through Retail Pharmacy (in Million US$), 2023-2028
Figure 29: Global: Allergy Immunotherapies Market: Online Sales (in Million US$), 2017 & 2022
Figure 30: Global: Allergy Immunotherapies Market Forecast: Online Sales (in Million US$), 2023-2028
Figure 31: Europe: Allergy Immunotherapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Europe: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: North America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: North America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Asia Pacific: Allergy Immunotherapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Asia Pacific: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Middle East and Africa: Allergy Immunotherapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Middle East and Africa: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Latin America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Latin America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2023-2028